New program helps men fight prostate cancer side effects
NCT ID NCT03660085
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested a program to help men prepare for and manage side effects from prostate cancer treatments like surgery or radiation. The program used daily texts and emails, plus support from other men, to encourage healthy habits before treatment. The goal was to reduce distress and improve quality of life. 140 men participated in the completed trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
140 people
The number who actually took part.
- Started
-
Dec 2019
- Finished
-
May 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * History of prostate cancer diagnosis * Non-metastatic stage at start of study * Approval from screening physician to participant in study * Existing (or willingness to create) email account * Ability to access and use daily email +/- text messages * Ability to understand and speak English language * Ability to participate in low to moderate levels of physical activity * Scheduled for a Radical Prostatectomy (RP) or curative intent Radiotherapy (RT)(external bean or bratty) or adjuvant or salvage RT post RP. Patient on Hormone therapy are eligible if they are scheduled to undergo RP or RT. * If deemed necessary by study physician, approval from family physician or oncologist to participate in the study Exclusion Criteria: * Unable to travel to Halifax for study visits (3 in total) * Unable to access the internet and lack of a computer/cellphone to receive emails required for study intervention * Patients being treated with Hormone therapy only * Patients on Active Surveillance * Patients deemed unfit to participate in low level exercise
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prostate cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- RE-irradiation for isolated FOCal recurrence of prostate cancer with ultrahypofracted SBRT: the RE-FOCUS study - pushing the boundaries of precision and efficacy
- A sharper eye for cancer: new PET tracer targets hidden tumors
- Can a radioactive tracer help surgeons find hidden prostate cancer?
- Steam therapy vs. surgery: can a less invasive fix help men with blocked urine flow?
- Can smart fluid monitoring improve robotic prostatectomy outcomes?
- Smart blood pressure monitoring may shield kidneys during robotic surgery